-
10.13.2021
10 Best Stocks to Buy According to Highbridge Capital
In this article we will take a look at the 10 best stocks to buy according to billionaire Glenn Russell Dubin’s Highbridge Capital Management. At the end of Q1 2021, the value of Highbridge Capital...
Read More -
08.17.2021
FDA Grants Orphan Drug Designation to CFT7455 for Multiple Myeloma
The FDA has granted orphan drug designation to CFT7455 for the treatment of multiple myeloma, according to a press release from manufacturer C4 Therapeutics. Adam Crystal, MD, PhD, chief medical officer of C4 Therapeutics, is...
Read More -
07.20.2021
TMRW Life Sciences Raises $105 Million to Accelerate Global Rollout of World’s First Automated Platform for IVF Egg & Embryo Management
The financing highlights the increasing demand for innovation and automation in the management of soon-to-be hundreds of millions of frozen eggs and embryos used in IVF. The equity round was led by Transformation Capital and...
Read More -
07.19.2021
C4 Therapeutics Stock Enters Leadership Territory
On Monday, C4 Therapeutics (CCCC) got an upgrade to its Relative Strength Rating, from 76 to 84. The RS Rating over 80 makes C4 Therapeutics stock one to watch. When looking for the best stocks...
Read More -
06.01.2021
Nonalcoholic beer maker Athletic Brewing raises $50M
Nonalcoholic beer maker Athletic Brewing has raised a $50 million Series C funding round led by Alliance Consumer Growth and existing investor TRB Advisors. This brings Athletic’s total funding to $70 million, co-founder and CEO...
Read More -
03.01.2021
Glenn Dubin joins Board of Directors of C4 Therapeutics
C4 Therapeutics is committed to transforming the treatment of cancer and other diseases with novel early-stage therapies that show a promising ability to eliminate disease-causing proteins. The company’s approach to medicine harnesses the innate machinery...
Read More -
02.03.2021
TMRW Launches World’s First Automated Platform to Safeguard Millions of Frozen Eggs and Embryos Used in IVF
The company announces that it has launched the world’s first automated cryo specimen management solution for embryos and eggs used in in vitro fertilization (IVF). TMRW’s proprietary platform has been installed in multiple premier fertility...
Read More -
10.10.2019
Frequency Therapeutics Commences Dosing in its Phase 2a Study of FX-322 for Sensorineural Hearing Loss; FDA Grants FX-322 Fast Track Designation
Frequency Therapeutics (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced that dosing has commenced in...
Read More -
10.02.2019
Frequency Therapeutics Announces Pricing of Initial Public Offering
Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced the pricing of its...
Read More -
05.29.2019
Dubin & Co. completes Series A investment in women’s reproductive health company TMRW
TMRW, the NYC-based creator of a Robotic Process Automation (RPA) platform designed specifically for in vitro fertilization (IVF), raised over $12M in Series A financing. The round was led by Special Situations’ Life Sciences Innovation...
Read More -
05.12.2015
TIMELINE-Castleton: From Louis Dreyfus energy arm to commodities powerhouse
Castleton Commodities has agreed to buy Morgan Stanley’s physical oil business, the biggest acquisition yet for the Stamford, Connecticut commodities trading house backed by hedge fund heavyweights. The firm’s roots go back almost 20 years...
Read More -
01.02.2013
Dubin acquires global energy merchant company Castleton Commodities International
Dubin, along with a prominent group of global investors – including investment vehicles established by family trusts created by Paul Tudor Jones and Timothy Barakett – acquire Castleton Commodities International LLC (“CCI”), a global merchant...
Read More
